# Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis

> **NCT00963833** · — · COMPLETED · sponsor: **Bayer** · enrollment: 68 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b (Betaseron, BAY86-5046)

## Key facts

- **NCT ID:** NCT00963833
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-17
- **Primary completion:** 2016-04-12
- **Final completion:** 2016-09-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00963833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00963833, "Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00963833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*